CD4 T-cell subsets and tumor immunity: the helpful and the not-so-helpful
about
Interest of Tumor-Specific CD4 T Helper 1 Cells for Therapeutic Anticancer Vaccineαβ TCR-mediated recognition: relevance to tumor-antigen discovery and cancer immunotherapyRestoring Lost Anti-HER-2 Th1 Immunity in Breast Cancer: A Crucial Role for Th1 Cytokines in Therapy and PreventionTrends and advances in tumor immunology and lung cancer immunotherapyEmerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasisAntitumor Effect of KML-B-Treated Dendritic Cells via Induction of Lymphocyte Activation.Anti-HER2 CD4(+) T-helper type 1 response is a novel immune correlate to pathologic response following neoadjuvant therapy in HER2-positive breast cancerInfluenza virus-like particles engineered by protein transfer with tumor-associated antigens induces protective antitumor immunity.Apigenin: Selective CK2 inhibitor increases Ikaros expression and improves T cell homeostasis and function in murine pancreatic cancer.Plasma membrane vesicles decorated with glycolipid-anchored antigens and adjuvants via protein transfer as an antigen delivery platform for inhibition of tumor growthCpG expedites regression of local and systemic tumors when combined with activatable nanodelivery.New Strategies in Engineering T-cell Receptor Gene-Modified T cells to More Effectively Target MalignanciesChronic Activation of Innate Immunity Correlates With Poor Prognosis in Cancer Patients Treated With Oncolytic AdenovirusDevelopment and Evaluation of Biodegradable Particles Coloaded With Antigen and the Toll-Like Receptor Agonist, Pentaerythritol Lipid A, as a Cancer Vaccine.Immunoprevalence and magnitude of HLA-DP4 versus HLA-DR-restricted spontaneous CD4(+) Th1 responses against telomerase in cancer patients.mRNA-based dendritic cell immunization improves survival in ret transgenic mouse melanoma model.Interactions between immune challenges and cancer cells proliferation: timing does matter!Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunityElevated neutrophil-to-lymphocyte ratio is an independent poor prognostic factor in patients with intrahepatic cholangiocarcinoma.Immunological mechanisms of intravesical chitosan/interleukin-12 immunotherapy against murine bladder cancer.A Systematic Review of Immunological Studies of Erythema Nodosum Leprosum.MicroRNA-17 is downregulated in esophageal adenocarcinoma cancer stem-like cells and promotes a radioresistant phenotypeThe cryo-thermal therapy eradicated melanoma in mice by eliciting CD4+ T-cell-mediated antitumor memory immune response.Mycobacterium bovis Bacillus Calmette-Guérin Alters Melanoma Microenvironment Favoring Antitumor T Cell Responses and Improving M2 Macrophage Function.Boosting anti-HER2 CD4 T-helper responses in HER2 expressing ductal carcinoma in situ.Vaccines targeting helper T cells for cancer immunotherapy.Checkpoint Inhibitors for Non-Small Cell Lung Cancer Among Older Adults.Targeting B-cell malignancies through human B-cell receptor specific CD4+ T cells.Heparan Sulfate Proteoglycans Promote Telomerase Internalization and MHC Class II Presentation on Dendritic Cells.Checkpoint inhibitors and other novel immunotherapies for advanced renal cell carcinoma.T-lymphocyte homing: an underappreciated yet critical hurdle for successful cancer immunotherapy.Rationale for immune-based therapies in Merkel polyomavirus-positive and -negative Merkel cell carcinomas.Deficiency of AMPK in CD8+ T cells suppresses their anti-tumor function by inducing protein phosphatase-mediated cell death.Differentiated State of Initiating Tumor Cells Is Key to Distinctive Immune Responses Seen in H-RasG12V-Induced Squamous Tumors.CD8+ T Cells That Coexpress RORγt and T-bet Are Functionally Impaired and Expand in Patients with Distal Bile Duct Cancer.IL-1βR-dependent priming of antitumor CD4(+) T cells and sustained antitumor immunity after peri-tumoral treatment with MSU and mycobacteria.Combination therapy for melanoma with BRAF/MEK inhibitor and immune checkpoint inhibitor: a mathematical model.Tn-MUC1 DC Vaccination of Rhesus Macaques and a Phase I/II Trial in Patients with Nonmetastatic Castrate-Resistant Prostate Cancer.Aging increases cell-to-cell transcriptional variability upon immune stimulationThe prognostic role of tumor infiltrating T-lymphocytes in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis.
P2860
Q26782583-F0D71CA3-A990-484D-8FBF-F7A6396B734DQ26861133-BDFAC5BA-AAC5-4253-96B3-2734F378FAE5Q28067145-542F2BF3-1AE2-4345-A0A0-164EABFA0B0DQ28067674-DB6C8CC0-E215-4C16-A1B9-0C67E514CAA6Q28069422-0AC5BB12-A09B-4DFF-82EA-7046955E6A1DQ33786891-BCD8DFEA-AA2B-481B-B368-11600AD85186Q35807188-86A85952-A889-465B-8DDE-E2FA40D007E4Q36207818-6494B445-1432-43BC-AF0B-3EA310ED1461Q36267629-0BC1AAAA-37B7-44CB-961E-142475FED333Q36322686-A4E7F37E-2EEF-42E1-A307-8EEA7D2612A6Q36395752-DEE8CE50-A5AC-4A77-A679-3F52ED2BDFB7Q36558375-F29251BB-941E-469D-9998-4D836C58AC43Q36582785-4DD4226C-E61E-4886-BFD3-12E42BED4625Q36642860-C65392CF-B684-4DEE-BDA6-8E634109DA96Q37012876-7A3A6213-4485-4549-BA42-C0805FCE9D33Q37079145-CE4BE67D-6E76-4E3E-A713-1C0A9A5B93F2Q37304503-01167FC7-DAEE-421E-BF58-C224CEC92ADAQ37313139-4902211C-431D-4A8F-97A6-8A019D1F1E88Q37588227-76B5029D-4749-407F-B4FA-831AA4478189Q37616492-62009C56-CAED-40F7-B167-E8420A18A7C3Q37695062-3E642B89-02A1-4031-9859-D31F12C55204Q37706921-4740B646-3ACE-4031-A4E7-805037159728Q37745399-B49B95F0-9B2A-41A2-8D8E-0C399D67FEC5Q38604832-EF7EFF66-C839-479C-8AB6-F2A7A6FB29B9Q38648122-594FF261-B5C7-42D5-8F02-AD70367D3431Q38649958-9E44F484-50E8-4792-BC8B-F6433C4637B1Q38654099-F452AF43-769D-48CD-889A-862F1211E9CDQ38725117-9AD22656-E220-46A4-8F44-EDF53400A633Q38754328-37A6F418-8469-49A3-9688-69BDD739B53AQ38870929-A2C718B0-38D2-4CDF-9404-7F5080795101Q38873974-E6D3D672-F8CA-4C29-B722-2B46381E7E5BQ38887303-5BB93CA4-FF49-4326-8E00-0EA43E25E530Q38901228-F10E6FAE-64EF-4B19-9CCB-63AE1B66CF45Q38991275-EDF90D9D-9B91-4206-B1FC-57F89412F806Q40385196-9144D84C-F897-4737-B8B3-613C7317652DQ40449413-1120A9C0-C2D2-49C7-9CC2-73D5137E3607Q41064188-F2F97FE6-E329-4290-9489-B6C1B9A7BAF6Q41636538-6A1E6587-0C03-47C8-B7C0-A86C678E9310Q42144472-44E4E032-5A84-49BB-B044-8FFD973501AFQ47320798-E6540099-7405-4469-9FC0-464B980688DC
P2860
CD4 T-cell subsets and tumor immunity: the helpful and the not-so-helpful
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
CD4 T-cell subsets and tumor immunity: the helpful and the not-so-helpful
@ast
CD4 T-cell subsets and tumor immunity: the helpful and the not-so-helpful
@en
CD4 T-cell subsets and tumor immunity: the helpful and the not-so-helpful
@nl
type
label
CD4 T-cell subsets and tumor immunity: the helpful and the not-so-helpful
@ast
CD4 T-cell subsets and tumor immunity: the helpful and the not-so-helpful
@en
CD4 T-cell subsets and tumor immunity: the helpful and the not-so-helpful
@nl
prefLabel
CD4 T-cell subsets and tumor immunity: the helpful and the not-so-helpful
@ast
CD4 T-cell subsets and tumor immunity: the helpful and the not-so-helpful
@en
CD4 T-cell subsets and tumor immunity: the helpful and the not-so-helpful
@nl
P3181
P1476
CD4 T-cell subsets and tumor immunity: the helpful and the not-so-helpful
@en
P2093
P3181
P356
10.1158/2326-6066.CIR-13-0216
P407
P577
2014-02-01T00:00:00Z